Prince Bawuah PhD
Biography (Adj. Prof. Prince Bawuah)
Prince is a young Ghanaian scientist, who obtained his senior high
school education at Tepa Senior High School and completed a
bachelor in Science Education at the University of Education
Winneba, Ghana. With fully funded Finnish Government
scholarships, he graduated from the Master Degree Program in
Photonics in May 2013, continued with his PhD in Physics studies
in August 2013 and graduated with Distinction in January 2017 at
the Department of Physics and Mathematics, University of Eastern
Finland. His significant contributions to the field of pharmaceutics
during his PhD research gained international recognition
(https://www.eurekalert.org/pub_releases/2017-01/uoef-nsm011017.php,
https://www.alphagalileo.org/ViewItem.aspx?ItemId=171444&CultureCode=en).
Additionally, Prince holds a Diploma in Pharmaceutical Quality by Design (QbD) from the
University of Copenhagen, Denmark.
Following an excellent completion of his PhD, Prince spent almost a year at the School of
Pharmacy of the University of Eastern Finland as a postdoctoral researcher after which he
moved to Cambridge in June 2018. Although Prince is still at the early stage of his research
career, he has already contributed significantly to the fields of Pharmaceutics and
Photonics (see his publications). He has attended several international conferences and
workshops and have won several awards. For the past six years, Prince has been an active
reviewer to several pharmaceutics and photonics (optics) related journals. He has
supervised and is currently supervising many PhD and MSc research students.
Prince is currently working as a fulltime researcher in the Department of Chemical
Engineering and Biotechnology, University of Cambridge (see profile
https://thz.ceb.cam.ac.uk/group/Prince-Bawuah) and is an Adjunct Professor (Docent) in
Terahertz Physics in the Faculty of Science and Forestry, University of Eastern Finland.
Research Interests and impact
Prince’s current project is mainly focused on the development site-specific drug delivery
systems for the colon, inner ear, peritoneal cavity and breast.
Prince’s recent project that was sponsored by Innovate UK (I-UK) led to the development of
a novel prototype Process Analytical Technology (PAT) tool called TeraSolve
(https://www.youtube.com/watch?v=sHaC0o99c6w). TeraSolve is a fully automated at-line
monitoring tool for fast and non-destructive quality checking of pharmaceutical solid dosage
forms (tablets). This project which featured top industrial players (GlaxoSmithKline (GSK),
Huxley Bertram Engineering Ltd and TeraView Ltd) has been selected as one of only ten
projects whose progress will be monitored by I-UK.